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Summary 
The nonreceptor protein tyrosine kinase p56/ok (Lck) serves as a fundamental regulator of thy- 
mocyte development by delivering signals from the pre-T cell receptor (pre-TCR) that permit 
subsequent maturation.  However, considerable evidence supports the view that Lck also par- 
ticipates in signal transduction from the mature TCR. We have tested this conjecture by ex- 
pressing a dominant-negative form of Lck under the control of a promoter element (the distal 
Ick promoter) that directs high expression in CD4+CD8 + thymocytes, mature thymocytes, and 
peripheral T  cells, thereby avoiding complications that result from the well-documented ability 
of dominant-negative Lck to block very early events in tliymocyte maturation. Here we report 
that expression of the catalytically inactive Lck protein at twice normal concentrations inhibits 
thymocyte positive selection by as much as 80%, while leaving other aspects of T  cell matura- 
tion intact. This effect was studied in more detail in mice simultaneously bearing the male-spe- 
cific H-Yci/[3 TCR transgene and ovalbumin-specific DO101x/~ TCR transgene, where even 
equimolar expression of the dominant-negative Lck protein substantially vitiated the positive 
selection process. Although deletion of H-Ycl/~ thymocytes proceeded normally in male mice 
despite the presence of catalytically inactive Lck, modest inhibition  of superantigen-mediated 
deletion was in some cases observed. These data further implicate Lck in the propagation of all 
TCR-derived signals,  and indicate that even very modest deficiencies in the representation of 
functional Lck molecules could,  in humans,  profoundly alter the  character of the  peripheral 
TCR repertoire. 
T 
he fate of individual T  cells developing in the thymus 
is determined by the specificity of the TCRs they ex- 
press. The maturation of thymocytes expressing TCRs with 
potential reactivity with self-ligands is aborted by a process 
referred to as negative selection (1-5), whereas the matura- 
tion ofthymocytes expressing TCRs that are potentially re- 
active with foreign antigens presented by self-MHC-encoded 
molecules is promoted by a process termed positive selec- 
tion (6-9). Since intrathymic selection events are clonally re- 
stricted and TCR specific, they are thought to be a conse- 
quence of TCR-mediated signals  stimulated by self-ligands 
presented on thymic stromal cells. 
Previous studies  demonstrate  that positive selection in- 
volves at least two distinct stages  (10-14). The development 
of thymocytes from CD4+CD8 + (DP) 1 to CD4  high CD8  l~ 
or  CD41~  h stages  occurs  independently  of class  I 
and II molecules, and hence is possibly mediated by CD4- 
and CDS-independent signals.  Further development to the 
mature CD4+CD8 -  and CD4-CD8 + single positive  (SP) 
thymocyte stages is mediated by signals  dependent on CD4 
and CD8 molecules, a conclusion supported by the obser- 
vation  that  no  mature  CD4  or  CD8  SP  thymocytes are 
generated in MHC class II or I knockout mice, respectively 
(10-14).  Although  the  molecular  mechanisms  governing 
each step  of the  positive selection process have  not been 
fully resolved, there are emerging views from recent pub- 
lished reports. When the TCRs on DP thymocytes are en- 
gaged with  anti-TCR  rnAb  in  vitro,  transcription  of re- 
combinant-activating  gene  (RAG)  1  and  R_AG-2  in  DP 
tAbbreviations used in this paper: B6, C57BL/6; DLGKR mouse, a domi- 
nant-negative lck transgenic mouse; DN, double negative;  DO10Tg, anti- 
OVA TCR-~x/13 transgenic; DP, double positive; FCM, flow cytometry; 
Fyn, p59r  hGH, human growth hormone; HSA, heat-stable antigen; 
H-YTg, anti-H-Y TCR-~x/[~ transgenic; Lck, p56tck; LM, littermate; PI, 
propidium iodide; RAG-l, recombination-activating  gene 1; SP, single 
positive; Tg, transgenic; ZAP-70, zeta-associated  protein. 
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Volume 184  September 1996 931-943 thymocytes is  turned  off (15,  16),  expression  of CD4  and 
CD8 is downregulated  (17,  18),  and  surface expression  of 
CD69 is induced  (17,  19, 20).  These changes occur in the 
first step  of thymic positive  selection  within  the  DP  thy- 
mocyte population,  since  the  first  distinct  population  ob- 
served  during  positive  selection  is  comprised  of CD69 + 
CD41~176  thymocytes (17). More recently, qualitative 
differences  in  signal  transduction  controlling positive  and 
negative selection have been reported.  Activation of p2F  ~-' 
and mitogen-activated protein kinase kinase (MAPKK) ap- 
pears  to  be  required  for thymic positive  but  not  negative 
selection (21, 22). Similarly, the activation of calcineurin, a 
calcium- and calmodulin-dependent phosphatase,  is essen- 
tial  for the  first  step  of positive  selection,  but  calcineurin 
activation is not required  for negative selection in the thy- 
mus (23, 24). 
CD4 and  CD8 glycoproteins are  thought to participate 
in  TCR-mediated  signal  transduction  by  binding  to  the 
same class II or I MHC  molecules that are engaged by the 
TC1L (25, 26). The cytoplasmic domains of both CD4 and 
CD8 interact with the protein  tyrosine kinase  p56  t~k (Lck) 
(27-30),  an  essential  molecule  for  thymocyte  maturation 
(3l,  32) and for signaling in some transformed T  cell lines 
(33-35).  Although the association of Lck with CD4 is im- 
portant  for  effective  in  vitro  T  cell  responses  to  antigen 
(36), this fun&ion is not necessary for either the generation 
of CD4 T  cells  in the thymus or for helper T  cell develop- 
ment  (37).  Similarly,  Chart  et al.  (38)  reported  that CD8/ 
Lck association was not essential  for CD8 T  cell develop- 
ment in a TCB, transgenic  (Tg) model. 
In this study, we have examined the requirement for Lck 
activity in thymic positive and negative selection using Tg 
nfice created to express an enzymatically inactive Lck pro- 
tein,  bearing an arginine  for lysine substitution  at position 
273,  under  the  control  of the  distal  promoter  of the  lck 
gene (designated DLGKtL). In DLGKR Tg mice, the mat- 
uration ofthymocytes to the DP stage is normal, and there- 
fore, the effect of enzymatically inactive Lck on thymic se- 
lection  can  be  investigated.  Our  results  demonstrate  that 
thymic positive selection requires Lck activity. 
Materials  and Methods 
Assembly of DLGKR Expression  Vector.  Previous  work  has 
shown that elements  within the lck gene contribute to transcrip- 
tional  regulation  and  copy  number-dependent  expression  of 
transgenes  (39). To preserve  elements  of this regulation,  we used 
a piece of the lck gene that had previously been modified in three 
ways  (32). First, lysine  codon 273  was  changed to an  arginine 
codon to encode a catalytically  inactive  kinase.  Second,  the lck 
3'-untranslated  region was  substituted  with  the  3'-untranslated 
region from the human growth hormone (hGH) gene, to provide 
a tag for detection of transgene  integration and transgene-specific 
transcripts.  Finally,  several  out-of-frame  ATG  codons  in  the 
5'-untranslated  region  were  deleted.  These  codons  had  previ- 
ously been shown to interfere  with translation  of the lck transcript 
(40). A  9.6-kb fragment, including the  entire  lck  coding region 
and  the  hGH  3'-untranslated  region,  was  removed  from  the 
IckR273  construct  (32) by  partial  digestion  with  BamHI  and 
complete  digestion  with  NotI.  A  7-kb  BamHl/NotI  fragment 
containing the Ick distal promoter in pUC19 (41) was then ligated 
to provide the expression  vector designated  pDLGKR with  the 
1ckR273 genomic fragment juxtaposed to the Ick distal pronmter. 
The diagrammatic  representation  of the DLGKP, transgene  is de- 
picted in Fig. 1 A. 
Animals.  C57BL/6  (B6), CBA/J,  and  BALB/c  mice  were 
purchased from Clea Inc. (Tokyo,  Japan). The dominant-negative  Ick 
Tg imce (I)LGKR mice) were produced by injection  of a 13.6-kb 
Notl  fragment  from  pDLGK1L  into  (DBA  ￿  B6)F 2 embryos. 
Transgene-positive founders were backsrossed  to B6 mice to es- 
tablish lines. Transgene expression  was determined by analyzing 
total cellular 1LNA from thymocytes and splenocytes  of DLGKR 
mice (Fig. 1 B). Anti-H-Y TCIL-c~/]3 Tg (H-YTg) mice (5) were 
established by Drs. H. von Boehmer and M. Steinmetz (Basel In- 
stitute for hmnunology, Basel, Switzerland), and provided by I)r. Al- 
fred Singer (National Cancer Institute, National Institutes of Health 
[NIH]  Bethesda,  MD).  Anti-OVA  TCR-oj[3  Tg  (DO10Tg) 
nfice  (42) were  kindly  provided  by Dr.  Dennis  Loh  (Nippon 
Roche Research Center, Kanagawa, Japan).  All mice used in this 
study were maintained under specific pathogen-free conditions. 
RINTI Analysis by Northern Blotting.  Total  cellular  RNA  was 
isolated from unfractionated thymocytes and splenocytes,  accord- 
ing to a method described by Chomoczynski and Sacchi (43). 10 ~,g 
of RNA for each sample  was fractionated  on  I% formaldehyde 
gels and transferred  onto nylon membranes  (Hybond-N; Amer- 
sham International,  Amersham, Bucks,  UK). The blot was subse- 
quently hybridized with 32p-labeled full-length lck eDNA, visual- 
ized  by  autoradiography,  and  analyzed  by  Phosphorhnager. 
Because  the  total  abundance  of lck  transcript  in  thymocytes is 
nmch higher than  that in splenocytes,  the duration  of exposure 
was  varied  to  allow optimal  visualization  of the  distinct  signals 
representing the endogenous and transgene-derived transcripts. 
Reagents.  The  reagents  used  in  this  study  were  as  follows: 
FITC-conjugated anti-TCP,-(x/[B-FITC  (H57-597-FITC)  (44), 
anti-TCR.-eL/~3-biotin  (H57-597-biotin),  anti-heat-stable  antigen 
(HSA)-FITC  (J11d-FlTC)  (45), anti-H-Y  Tg  TCR-c(-F1TC 
(T3.70-FITC)  (46), anti-Qa-2-biotin  (1-9-9-biotin)  (47), and 
anti-CDS-APC (53-6.72-APC)  (48) were prepared in  our labo- 
ratory.  PE-conjugated  anti-CI)4  mAb  (GK1.5-PE)  was  pur- 
chased  from  Becton  Dickinson  hnmunocytometry  Systems 
([BDIS],  Mountain View, CA). Anti-TCRV~7-FITC (TR311)- 
FITC)  and  anti-CD69-FITC  (H1.2F3-FITC)  were  purchased 
from PharMingen (La Jolla,  CA). Anti-DOl 0 Tg TCR-~ (KJ-1) 
(49),  anti-TCP,  V[g6 (44-22-1)  (50),  anti-VlB1 l  (RR3-15)  (51), 
anti-VI35  (MR9-4) (52), anti-TCRV[38.2 (F23.2)  (53), and anti- 
FcRyI mAbs (2.4G2)  (54) were used as culture supernatants.  PE- 
conjugated streptoavidin  (PE-avidin)  and Texas  red-avidin  were 
purchased  from  GIBCO-BRL,  Gaithersburg,  MD).  Polyclonal 
goat anti-mouse  IgG-FITC was purchased from Southern Bio- 
technology Associates,  Inc.  (Birmingham,  ALl.  Polyclonal  goat 
anti-rat IgG-FITC was purchased from Cappel (Durham, NC). 
Immunofluorescent Staining and Flow Cytometry Analysis.  Freshly 
prepared thymocytes were suspended in PBS supplemented with 
2% FCS and 0.1% sodium azide.  In general,  10" cells were incu- 
bated on ice for 30 rain with appropriate staining  reagents  as de- 
scribed  (55). For direct staining,  cells were  first incubated  with 
2.4G2 to prevent nonspecific  binding of mAbs via FcR interac- 
tions.  For indirect  flow cytometry (FCM)  analysis, thymocytes 
were  first incubated  with  culture  supernatant  of anti-T('P.V[3 
mAbs followed by goat anti-rat  IgG-FITC or goat anti-mouse 
IgG-FITC. The stained  cells were washed extensively  and then 
anti-CD4-PE and anti-CD8-APC were added after blocking of 
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FCM analyses, electronic compensation was done by using cell 
mixtures of positive and negative cell populations in each fluores- 
cence emission.  FCM analysis was performed on FACSvantage | 
(BDIS),  and fluorescence  data were collected  as a list mode on 
40,000  viable cells as determined by light scatter parameters  and 
propidium iodide (PI) exclusion.  Where indicated, 400,000  cells 
were  collected.  FACSvantage  |  and CELLQuest  |  software  pro- 
grams (BDIS) were used for collecting and analyzing data. 
Purification of CD4+ CD8  + DP Thymocytes.  DP  thymocytes 
were isolated by adherence to plates coated with anti-CD8 mAb 
(83-12-5), and were >96% CD4+CD8 + as described  (56). 
Immunoprecipitation and Immunoblotting.  lmmunoprecipitation 
and immunoblotting  with antiphosphotyrosine mAb (4G10; Up- 
state Biotechnology, Inc., Lake Placid,  NY), anti-Lck antiserum 
(4F688, specific for a part of the unique sequence ofLck, RNG- 
SEVRDPLVTYEGSLPPASPLQDN; a gift from Dr. Larry Samel- 
son, NIH), and anti-TCR-~ antiserum (4r  a gift from Dr. Al- 
fred  Singer,  NIH) were performed as previously described  (55, 
56). In brief,  thymocytes were solubilized in 1% digitonin lysis 
buffer (50 mM Tris, pH 7.4, 0.15 M  NaC1, l  mM sodium vana- 
date,  and 1 mM EDTA). Cell lysates were immunoprecipitated 
with  protein  G-Sepharose  preabsorbed  with  anti-CD4  mAb 
(GK1.5),  anti-CD8 mAb (53-6.72),  or anti-Lck antiserum. The 
immunoprecipitates were applied  to  10% SDS-PAGE under re- 
ducing conditions and then subjected to electrotransfer  to polyvi- 
nylidene difluoride nylon membranes. The membranes were in- 
cubated  first  with  3%  FCS  containing PBS  for  1  h  at  room 
temperature, and then with h200-diluted anti-Lck antiserum or 1 
Ixg/ml of antiphosphotyrosine  mAb  (4G.10)  in PBS  containing 
0.4% Tween-20.  For  immunoblotting with  4G.10  ,nAb,  the 
membrane was washed and then incubated with horseradish  per- 
oxidase-conjugated protein A  (Cappel).  A  chemiluminescence 
detection system  (ECL;  Amersham International) was  used  for 
4G.10 immunoblottings. Protein A-/esI  was  used for  immuno- 
blottings  with  anti-Lck  antiserum.  The  band  intensities were 
measured by a densitometer and an arbitrary  densitometric unit 
was assigned to each band. 
In  Vitro Immune Complex Kinase Assay.  Immune complex ki- 
nase assays were performed as described  (57). In brief,  cells were 
solubilized at a concentration of 10~/ml in lysis buffer (50 mM 
Tris,  pH 7.4,  0.15  M  NaC1, and 1 mM sodium vanadate)  con- 
taining digitonin at  1%.  Cell  lysates were  immunoprecipitated 
with anti-CD4 mAb (GK1.5), anti-CD8 mAb (53.6-72),  or anti- 
Lck antiserum (#688) preabsorbed to protein G-Sepharose. The 
specificity of bands running at the expected size of Lck from the 
imnmnoprecipitates with  anti-Lck  antisera  was  confirmed  by 
adding the appropriate  antigenic peptides during immunoprecipi- 
tation and monitoring the  disappearance  of the  relevant band. 
After  incubation,  beads  were  washed  in  lysis buffer  lacking 
EDTA and sodium vanadate,  and then incubated with 15 b~Ci  of 
y-[32p]ATP  (5,00{) Ci/mmol; Amersham International) for  5 or 
15 rain on ice in kinase buffer (20 mM Hepes,  pH 7.5,  100 mM 
NaC1,  5  mM  MgC12,  5  mM  MnC12, and  1  ~M  non-radio- 
labeled ATP). Kinase reactions were quenched with 50 ml of 2 X 
Laemmli sample buffer with 4 m/Vl EDTA and resolved on 10% gels. 
Results 
Gene Dose-dependent Reduction  in the Generation  of Mature 
SP Thymocytes  in DLGKR Mice.  The requirement for Lck 
tyrosine kinase activity in thymic positive and negative se- 
lection  was  examined  in  a  Tg  mouse  strain  (DLGKR) 
overexpressing  catalytically inactive  LckR273  under  the 
control of the distal Ick promoter. In contrast to the proxi- 
mal kk promoter, the distal lck promoter, when used in Tg 
mice, is 5-10 times more active in mature thymocytes and 
peripheral T  cells than in CD4-CD8-  cells (41).  We rea- 
soned, therefore, that the DLGKR mouse might provide a 
good model system for analyzing the role of Lck in thymic 
selection. The characteristics of DLGKR thymocytes were 
examined by comparing the  FCM profiles of normal, Tg 
heterozygous (DLGKR  /+) and homozygous (DLGKR  +/+) 
DLGKR mice. Yields of thymocytes among these different 
mice were essentially similar (data not shown). CD4/CD8 
profiles (Fig.  2,  top) revealed normal numbers of DP  thy- 
mocytes  in  both  Tg  heterozygous  and  homozygous 
DLGKR mice as compared with normal littermates (LM), 
however,  a  gene  dose-dependent  reduction  of CD4  SP 
cells was noted. These characteristic profiles were obtained 
from  seven  independent experiments.  The  frequency  of 
TCR-0L/~  high CD4  and  CD8  SP  mature thymocytes was 
determined by three-color FCM analysis with anti-TCR, 
anti-CD4, and anti-CD8 reagents, and a similar type of de- 
crease was detected in both SP thymocyte subpopulations 
of DLGKR mice. 
Figure  1.  Diagrammatic  representation  of the DLGKR transgene and 
its pattern of expression. (A) The mouse/ok  gene (exon 1-t"2) with a Lys- 
to-Arg mutation at codon 273 was engineered  into a vector that contains 
the Ick distal promoter. Exon 12 is fused to the poly(A) signal from the 
3'-untranslated region of the hGH gene. See Materials and Methods for a 
detailed description. (/3) Transgene  expression  was determined by analyz- 
ing total cellular RNA from thymocytes and splenocytes of control (C) 
and Tg animals. A 32p-labeled  lck cDNA probe detects both the endoge- 
nous and transgene-derived  transcripts. Exposure time for the thymocyte 
panel was 8 h and for the splenocyte panel, 24 h. The relative ratio of 
transcript abundance  was determined by PhosphorImager  analysis. 
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Figure 2.  Phenotypic characterization of 
thymocytes of DLGKR. mice Thymocytes 
were  prepared  from g-wk-old Tg-  LM, 
DLGKR  Tg  heterozygous  (Tg-/*),  and 
DLGKR  Tg  homozygous  (Tg  +~+)  mice, 
and  stained  with  anti-TCP.-~/~-HTC, 
anti-CD4-PE,  and  anti~CDS-APC  (top), 
anti-HSA-FITC  and  anti-Qa-2-biotin  fol- 
lowed by avidin-PE (middle), or anti-TCR- 
c~/IB-FITC (bottom). Representative profiles 
of CD4/CDS, HSA/Qa-2, and TCR.-~/13 
are denmnstrated. The percentages of cells 
present in  each area are indicated. Arrows 
denote  the  cells with  increased TCI<  ex- 
pression  on  TCI<  a""  positive  thymocytes 
(bottom). The percentages of TCR hi,~h cells 
in CD4 SP thymocyte subpopulation calcu- 
lated from the data shown (top) were 8.49% 
in LM (Tg-), 7.12% in I)LGKR (Tg ~+), 
and 3.45% in DLGKR  (Tg  +;~) mice. The 
percentages of TCR  high cells in  cI)g  SP 
thymocyte  subpopulation  were  2.10%  in 
LM  (Tg  " ),  1.90% in  1)LGKR  (Tg  '+), 
and 1.50% ill DLGKR (Tg  *§  mice. 
To  clarify further  the  differentiation  status  of SP  thy- 
mocytes in DLGKP, mice, additional T  cell differentiation 
markers were  analyzed (Fig. 2,  middle  and bottom).  Among 
SP thymocytes, functionally mature thymocytes manifest a 
HSA  Qa-2 + phenotype (47). The number ofHSA-Qa-2 + 
cells in DLGKR  mice decreased in a gene dose-dependent 
manner (Fig. 2, middle)￿9 Similarly, a single-parameter histo- 
gram of TCR-ot/13  revealed decreased numbers  of TCR- 
0~/~  high  mature  thymocytes in DLGKR  mice  (Fig.  2,  bot- 
tom).  tn addition, increased TCP,.  expression was detected 
in  DLGKR.  DP  thymocytes  (arrows,  Fig.  2,  bottom;  data 
not  shown).  This  characteristic  phenotype  of  DP  thy- 
mocytes has been observed in anti-CD4 mAb-treated (58), 
MHC  class II-negative (59), and CD4 Tg mice (57), and in 
in vitro 37~  cultured DP thymocytes (55),  and is consis- 
tent with the view that Lck activity reduces the fidelity of 
TCR  assembly (57). 
Cell  SuoCace  Expression  of  CD69  in  DLGKR  Mice. 
CD69,  an  early activation antigen  expressed on  ~10%  of 
normal  thymocytes,  was  shown  to  be  a  marker  of thy- 
mocytes undergoing TCR-mediated thymic selection (17, 
19,  20).  The surface expression of CD69  in the thymus is 
thought  to  be  a  consequence  of  intracellular  signaling 
events initiated by TCR  engagement of ligands on thymic 
stromal  cells￿9 All  CD69 +  thymocytes  express  TCR-ot/13 
and  they include  a  fraction  of DP  thymocytes and  about 
one half of the CD4 and CD8 SP thymocytes (17). Conse- 
quently,  we  examined  CD69  expression  on  fresh  thy- 
mocytes  of normal,  DLGKR,  heterozygous,  and  DLGKR 
homozygous mice. The  FCM analysis of flesh thymocytes 
stained with an anti-CD69 mAb is shown in Fig. 3,  t  W. A 
decrease  in  the  number  of  CD69 +  cells  was  seen  m 
DLGKR  mice  which  appeared to  be  dependent  on  gene 
dosage￿9 Thus, a change in CD69 expression is another con- 
sequence of the expression of catalytically inactive Lck. 
We  have  previously demonstrated  that  DP  thymocytes 
express CD69 within a few hours after in vitro stimulation 
with  immobilized anti-TCP,  mAb  (17).  Thus,  we  evalu- 
ated the  ability of DLGKR  thymocytes to  express  CD69 
upon stimulation with anti-TCR  mAb.  Thymocytes from 
normal, DLGKR heterozygous, and DLGKR homozygous 
mice were stimulated for  14  h  at 37~  in vitro with anti- 
TCR  mAb (H57-597)  that had been precoated on plates at 
different  doses  (1-30  I*g/ml).  The  cultured  thymocytes 
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Figure 3.  CD69 expression on 
freshly prepared thymocytes and 
in  vitro  anti-TCR~timulated 
thymocytes  from  DLGKR 
mice.  (Top)  Cell surface expres- 
sion  of  CD69  on  thymocytes 
from Tg- LM, Tg heterozygous 
(Tg  /+), and homozygous (Tg  +/+) 
DLGKR mice was examined by 
FCM  analysis with  anti-CD69- 
HTC.  The  percent  representa- 
tion of CD69 + cells is indicated. 
(Bottom)  Thymocytes were stim- 
ulated on plates coated with anti- 
TCR  n~A.b (H57-597)  at  doses 
indicated at  37~  for  14  h.  The 
cells were  harvested and stained 
with  anti-CD69-FITC:  FCM 
analysis was then perfomled with 
PI  for  dead  cell  exclusion. The 
CD69  profiles  are  shown  with 
background  stainings (shaded  ar- 
eas).  The  percentage  of CD69 + 
cells  in each line was as follows: 
56.4,  48.4,  23.5,  and  12.1%  (in 
normal  LM  mice);  46.8,  35.2, 
14.0, and 8.0% (in heterozygous mice); and 32.1, 23.8, 8.4, and 4.8% (in homozygous mice) for anti-TCR stimulations at concentrations of ( 
(  .... )  10, ('"') 3, and (---)  1 Dg/ml, respectively. 
) 30, 
were harvested, washed, and then stained with anti-CD69- 
FITC. Dead cells were excluded from the FCM analysis by 
the use of PI. The CD69 profiles with control background 
stainings  are shown in  Fig.  3,  bottom. Normal thymocytes 
stimulated  with  immobilized  anti-TCR  mAb  express 
CD69  on  their  surfaces  in  a  dose-dependent  manner.  As 
compared with the normal LM  (Tg-/-),  CD69  induction 
was found to be less efficient in heterozygous (Tg+/-), and 
substantially  reduced  in  homozygous  (Tg+/+),  DLGKR 
mice.  These  results  suggest  that  Lck  contributes  to  the 
TCR-derived signaling pathway that  regulates  CD69  ex- 
pression. 
The Amount of Lck Protein in DLGKR Thymocytes.  We 
determined the amount of Lck protein in thymocytes from 
control LM and heterozygous DLGKR Tg mice. The Lck 
molecules were immunoprecipitated with anti-CD4 mAb, 
anti-CD8  mAb,  or anti-Lck antiserum,  and  then  the  im- 
munoprecipitates were  analyzed by immunoblotting with 
anti-Lck antiserum as described in Materials and Methods. 
The anti-Lck antiserum reacts with both endogenous normal 
and transgene-derived mutant Lck molecules. As shown in 
Fig.  4  A,  the  total  amount  of Lck protein  as  well  as  the 
amount of Lck coprecipitated with  CD4 and CD8  mole- 
cules  was  increased  about  twofold  in  DLGKR  mice.  A 
similar level of increase was also  observed in anti-Lck im- 
munoblottings by using total cell lysates (data not shown). 
Specific Reduction  of  Tyrosine  Kinase  Activity  of  Lck  in 
DLGKR Thymocytes.  To assess the extent to which cata- 
lytic  activity  was  preserved  among  Lck  molecules  in 
DLGKR mice, the  tyrosine kinase  activity of Lck in thy- 
mocytes of DLGKR mice was directly assessed. Lck associ- 
ated with CD4  or CD8,  and  the  total cellular Lck in  the 
digitonin  lysates from normal  and  heterozygous DLGKR 
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thymocytes  were  immunoprecipitated  with  anti-CD4, 
anti-CD8,  or anti-Lck reagents, respectively. As shown in 
Fig.  4 B, the kinase activity of Lck associated with CD4 or 
CD8  in  DLGKR thymocytes was  substantially decreased, 
as measured by autophosphorylation and by transphosphor- 
ylation of an exogenous substrate, enolase. In addition,  ty- 
rosine kinase activity per Lck protein in anti-Lck immuno- 
precipitates was also  decreased by at least twofold.  Similar 
results were  obtained in six independent  experiments,  in- 
cluding an experiment with titration of cell lysates used in 
immunoprecipitations (data not shown). 
Decreased Activation  of  Lck  upon  CD4  Cross-linking  in 
DLGKR Thymocytes.  The tyrosine kinase activity of CD4- 
associated Lck is increased when CD4 molecules are cross- 
linked  (60).  Consequently,  we  assessed  the  activity  of 
CD4-associated Lck after cross-linking of CD4 in DLGKR 
thymocytes. Since Lck in freshly prepared thymocytes were 
heavily phosphorylated by continuous CD4 engagement in 
vivo  (52,  54),  thymocytes  from  heterozygous  DLGKR 
mice were first cultured at 37~  overnight. The cells were 
then  stimulated  with  IgM  anti-CD4  mAb  (RL-172)  for 
5-10 rain  as described  (57).  Lck kinase  activity associated 
with CD4 was assessed by immunoprecipitation with anti- 
CD4 (GK1.5) using an in vitro immune complex kinase as- 
say.  Increased  kinase  activity at  the  5-rain  time  point  in 
control  non-Tg  thymocytes was  observed,  however,  this 
induction  was  reduced  and  delayed in  DLGKR  Tg thy- 
mocytes  (Fig.  4  C).  This  result  almost  certainly  reflects 
competition by the overexpressed inactive Lck protein for 
CD4 molecules. 
Tyrosine Phosphorylation of TCR-~ in DP Thymocytes from 
DLGKR Mice.  Tyrosine  residues  of  TCR-~  in  freshly 
prepared  DP  thymocytes  are  phosphorylated  (56)  and  a Figure 4.  The amount of protein and tyrosine ki- 
nase activity of Lck m I)LGKR thymocytes. I)i~to- 
nin cell lysates were prepared from normal and het- 
erozygous DLGKP, thymocytes. The Lck associated 
with CD4 or CD8 and total cellular Lck were immu- 
noprecipitated with  anti-CD4,  anti-CD8  mAb, or 
anti-Lck antiserum, respectively. The amount of Lck 
protein was visualized  by immunoblotting with anti- 
Lck antiserum (A). Tyrosine kinase activity in each 
precipitate was detennined by in vitro immune com- 
plex kinase assay  (B). In addition to autophosphoryla- 
tion  of Lck, enolase was  used  as  an  indicator  of 
transphosphorylation activity. The  phosphorylated 
proteins migrating at the  expected size of Lck and 
enolase are indicated. Arbitrary' densitometric units 
are indicated under each band. The values normal- 
ized for the amount  of Lck protein present in each 
precipitate are also demonstrated. In C, thymocytes 
were first cultured at 37~  overnight and then stimu- 
lated with IgM anti-CD4 mAb (RL-172) for another 
5-10  ram.  Lck kinase activity associated with  C1)4 
was assessed  by immunoprecipitation with anti-CI)4 
(GK1.5) and after in vitro imnmne  complex kmase 
assay. Arbitrary densitometric units are indicated un- 
der each band. 
substantial portion of the  phosphorylation on  TCR.-~  de- 
tected in fresh DP thymocytes is mediated by CD4-associ- 
ated  Lck  in  vivo  (57).  It would,  therefore,  be  anticipated 
that reduced { phosphorylation would occur in the DLGKR 
mice.  We  evaluated the phosphorylation status of TCP,-~ 
in fresh DP thymocytes as well as the ability of CD4-associ- 
ated Lck  to  rephosphorylate TCR.-~  in  DLGKR  DP  thy- 
mocytes. DP thymocytes were purified from heterozygous 
DLGKR  mice,  and  tyrosine  phosphorylation  on  TCR-~ 
was  assessed  by  inmmnoprecipitation  with  anti-TCP,-[B 
mAb (H57-597)  and immunoblotting with antiphosphoty- 
rosine mAb (4G. 10). A 50% decrease in tyrosine phosphor- 
ylation  on  TCR.-~  was  detected  in  freshly  prepared 
DLGKR  DP  thymocytes (Fig. 5  A), although  the amount 
of TCR.-~ protein in the same precipitates, assessed by im- 
munobtottmg  with  anti-TCR-~  antiserum  (46551),  was 
equivalent (Fig. 5  B). 
To  evaluate the capacity of CD4 cross-linking to stimu- 
late  TCR.-{  phosphorylation,  DP  thymocytes  were  cul- 
tured  at  4  or 37~  overnight,  and  then  stimulated for  30 
rain  with  anti-CD4  mAb  in  the  presence  of FcR  +  cells 
(56).  As  can  be  seen  in  Fig.  4  C,  rephosphorylation  of 
TCR-i~  after  CD4  cross-linking was  significantly reduced 
in  DLGKR. DP  thymocytes.  These  results provide further 
documentation  of the  reduced  Lck  kinase  activity associ- 
ated with CD4 in DLGKR  DP thymocytes. 
Effect qfi Overexpression  of Enzymatically  I, active Ix'k on Pos- 
itive  and Negative  Selection  of H-Y-  and  OVA-spec!fic  TCR- 
ee/~8 Tg Tkymocytes.  Another  system  that  allows  for  the 
evaluation of Lck involvement in the generation of SP thy- 
mocytes is the  use  of TCR  Tg mice.  DLGKR. mice were 
crossed  with  TCP,  Tg  mice  that  express  TCP,  derived 
from an H-Y-specific, H-2Db-restricted CTL clone whose 
ligand is the male antigen H-Y in the context ofH-2D t'. In 
the  H-2  b  female  H-Y  Tg  thymus,  Tg  TCR-expressing 
thymocytes  are  subject  to  positive  selection,  whereas  the 
transgene-expressing thymocytes are subject to negative se- 
lection  in  the  male  thymus  because  of the  expression  of 
both D t' and H-Y antigens (5, 8). The representative results 
of the  yield of thymocytes  and  the  CD4/CD8  profiles of 
female  and  male  H-Y/DLGKR.  double-Tg  mice  (heter- 
ozygous for DLGKR.) are shown in Fig. 6. The generation 
of CD4-CD8 + thymocytes in female mice bearing the H-Y 
TCR-(x/13 transgene was substantially reduced by the pres- 
936  P,  equirenlent for p56  ta' Activation in Thymic Selection Figure  5.  TCR-~ phosphorylation in  DP  thymocytes from DLGKR 
nfice.  (A)  Purified  DP  thymocytes from  heterozygous DLGKR  mice 
were  lysed  with  digitonin  in  the  presence  of phosphatase  inhibitors. 
TCR-~  was  immunoprecipitated  with  anti-TCR,-a/13  mAb,  and  the 
amount of tyrosiue phosphorylation was determined by immunoblotting 
with anti-phosphotyrosine mAb 4G10.  (/3) The amount of TCR-~ pro- 
tein on the same membrane was determined by using anti-TClk-~ antise- 
rum (#551).  (C) Purified DP thymocytes were first cultured at 4 or 37~ 
overnight, and then stimulated at 37~  for 30 rain with anti-CD4 mAb 
(GK1.5) in the presence of FcR  + LK35.2 cells.  The phosphorylation sta- 
tus of TCR-~ was determined by the same methods as in  (A).  Arbitrary 
densitometric units are indicated under each band. 
ence of catalytically inactive Lck, whereas the generation of 
DP and double negative (DN)  thymocytes was not influ- 
enced in either ungated or gated (Tg TCR-ot +) population. 
In contrast, CD4/CD8 profiles of male H-Y/DLGKR. dou- 
ble-Tg  (DLGKR Tg  -/§  animals  showed little difference 
in the extent of thymocyte deletion, indicating that nega- 
tive selection of H-Y T  cells is not significantly affected in 
the DLKGP. thymus. 
Next,  DLGKI< mice  (H-2  ~ background)  were  crossed 
with TCP. Tg mice (H-2  a background) that express  TCR 
derived from an OVA-specific I-Aa-restricted T cell hybri- 
doma (DO11-10).  In the H-2a-positive DO10 Tg animals, 
Tg  TClk-expressing  thymocytes are  subject  to  positive 
selection (42). In Fig. 7, representative CD4/CD8 profiles 
of  DO10/DLGKP.  double-Tg  mice  (heterozygous  for 
DLGKR) are demonstrated with yields ofthymocytes. The 
generation of CD4+CD8 -  thymocytes bearing DO10  Tg 
TCI< was dramatically reduced by the presence of catalyti- 
cally inactive Lck, whereas the generation of DP and DN 
thymocytes was not influenced. The results  obtained from 
DO10  Tg-  LM control mice  (H-2  b/a) provided a confir- 
mation of the results demonstrated in Fig. 2. 
Effect  of  DLGKR  on  Endogenous  Superantigen-mediated 
Thymocyte  Deletion.  Since negative and positive selection 
both result from TCR-mediated signals that should require 
Lck, we studied the effects of DLGKR expression on thy- 
mocyte deletion in more detail, making use of the intrathy- 
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Figure  6.  CD4/CD8  profiles of thymocytes from H-Y/DLGKR  double-Tg mice.  Thymocytes 
from  6-wk-old  H-Y/DLGKR  double-Tg mice were  stained with  anti-CD4-PE,  anti-CD8-APC, 
and anti-T3.70-FITC. Thymocytes from 6-wk-old normal B6 mice were stained with anti-CD4-PE 
and anti-CD8-APC.  H-Y  Tg mice used were  H-2  bxt', and DLGKR Tg negative (Tg  -/-)  or het- 
erozygous (Tg  /+).  Representative CD4/CD8  profiles of total thymocytes (Ungated) and electroni- 
cally gated Tg TCR-a + (T3.70 §  thymocytes (Gated) are depicted￿9 The yields of thymocytes in each 
mouse are 8.4 X  107, 9.8 k  107, 4.55 k  107, 4.15 X  107, and 12.0 X  l07 cells in H-Y Tg female LM, 
H-Y Tg female DLGKR heterozygous, H-Y Tg male LM,  H-Y Tg male DLGKR heterozygous, 
and age-matched B6 mice, respectively. The percentages of cells present in each area are also indicated. 
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Figure  7.  CD4/CD8  profiles of thymocytes from DO10/DLGKP, 
double-Tg mice. Thymocytes  from 6-wk-old DO10/DLGKR double- 
Tg mice were stained with culture supernatant of KJ-1 mAb followed by 
goat anti-mouse Ig-FITC, and anti-CD4-PE and anti-CD8-APC. R.ep- 
resentative CD4/CD8 profiles  of ungated thymocytes  of DO10 Tg- LM 
(top)  and  electronically gated Tg  TCP,,-tx  +  (KJ1  +)  thymocytes of 
DO/0TCR. Tg (bottom) are depicted. The yield of thymocytes in each 
mouse is shown as a boxed number￿9  The percentages of cells present in 
each area are also indicated. 
mic clonal deletion of VJ36-,  VI311-, V[37-, and VJ35-bear- 
ing  cells  in  mice  expressing retroviral superantigens,  e.g., 
(C]3A/J  ￿  B6)F~ animals (Mls-P, I-E  +)  (4).  The presence 
of the  retroviral superantigens Mls-P  and Mls-2  ~ in  these 
mice,  along with  expression  of MHC  class  II I-E  mole- 
cules, leads to deletion of V[36-, V[37-, and VJ311-bearing 
ceils  (61,  62).  The presence  of Mtv-9  gene  products  in 
B6 mice leads to deletion of VJ35-bearing T  cells  in  I-E  + 
mice (63). 
We  crossed  heterozygous  DLGKR  mice  of B6  back- 
ground to normal CBA/J mice. Three-color FCM analysis 
in  thymocytes was performed with  anti-CD4,  anti-CD8, 
and  mAbs  specific for TCRC[3,  TCtkVI36,  Vl311,  V[37, 
VI35,  or V[38.2.  As  shown  in  Table  1,  the  generation  of 
CD4 SP thymocytes was significantly inhibited in (CBA/ 
J  ￿  B6)F~ DLGKR Tg  + mice (leftmost column). This re- 
sult is consistent with the results obtained from the analysis 
of B6  background  mice  expressing  a  single  copy  of the 
DLGKI< transgene  (Fig.  2).  In the  (CBA/J  ￿  B6)F 1 non- 
Tg mice,  only a  small  number  of V[36, V[311,  and V[35 
cells  was  detected  in  the  CD4  SP  thymocyte subpopula- 
tion, as expected (4). No detectable rescue of CD4 SP thy- 
mocytes expressing V~6,  V~5,  or  V[311 TCP,  s was  ob- 
served  in  Tg  +  (CBA/J  ￿  B6)F~ animals.  Percentages  of 
VJ38.2  cells,  a  nondeleting  control  VI3,  were  not  signifi- 
cantly different between DLGKR Tg and non-Tg mice. 
In  the  CD8  SP  thymocyte  subpopulation,  statistically 
significant  rescue  of VJ36-bearing  cells  was  observed  in 
DLGKR Tg  + mice in both experiments 1 and 2  (boldface 
type).  In  contrast,  deletion  of VI311-,  VI37-,  and  VJ35- 
bearing cells in the CD8 SP thymocyte subpopulation was 
less efficient than that seen in CD4 SP thymocytes, and no 
significant  rescue  was  observed  in  DLGKR  Tg  +  mice. 
Thus, most of the endogenous superantigen-mediated clonal 
deletion of particular V~-bearing cells was not affected in 
DLGKR. mice. However, deletion of V~6-bearing cells in 
the CD8 SP thymocyte subpopulation was attenuated, sug- 
gesting that Lck may participate in signal transduction lead- 
ing to negative selection, at least in some cases. 
Discussion 
The  lymphocyte-specific protein  tyrosine  kinase,  Lck, 
first identified by virtue of its illegitimate activation in some 
lymphoid malignancies  (64),  plays pivotal roles in  antigen 
receptor  signaling.  Prior  studies  have  shown  that  Lck  is 
physically and  functionally  associated  with  the  CD4  and 
CD8  coreceptors,  the  [3  chain  of the  IL-2 receptor,  and 
with  numerous  other  lymphocyte  surface  proteins  (65). 
The importance of Lck function was dramatically demon- 
strated by the isolation of the JCaM1  cell line,  in which a 
mutation in the Ick gene compromises its expression, yield- 
ing lymphoblasts incapable of signaling via their antigen re- 
ceptors  (35).  Similarly, mice bearing a  targeted disruption 
of the lck  gene have very small thymuses and generate no 
functional  T  lymphocytes (31).  This  results  from the  ab- 
sence of Lck catalytic function, since Tg animals expressing 
high levels of catalytically inactive LckR.273 protein mani- 
fest similar or even more severe defects (32). 
Careful  analysis  has  defined  important  aspects  of the 
mechanism whereby Lck entrains  early thymocyte devel- 
opment (65).  Immature T-lineage progenitors colonize the 
thymus throughout early adult life,  and undergo a series of 
proliferative and differentiative steps to yield mature, func- 
tional T  lymphocytes. For conventional T cells, production 
of a functional ~  chain polypeptide through  13 locus gene 
rearrangement permits assembly of a pre-TCR, composed 
at a minimum of the CD3% fi, and ~ chains, a monomor- 
phic pre-Tot chain,  and the  J3 chain itself,  which  directly 
promotes the development of DP cells,  through a series of 
replicative steps from immature DN progenitors  (66,  67). 
Delivery of this pre-TCR signal clearly proceeds under the 
aegis of Lck, since transgenes encoding an activated version 
of Lck direct development of DP cells even in RAG-I-"- 
mice (68). 
Although  these  studies  have proved revealing with  re- 
gard to pre-TCR signaling, they leave open the question of 
whether the catalytic activity of Lck is essential for signaling 
from the TCR itself. Inhibition of Lck function arrests thy- 
mocyte development at the DN  stage,  and hence  mature 
CD3 + cells do not mature. We therefore used the lck distal 
promoter,  which  is  expressed  at  high  levels  in  DP  thy- 
mocytes,  mature  SP  thymocytes,  and  peripheral  T  cells 
(41),  to direct the expression of the same catalytically inac- 
tive form of Lck that had been previously shown to com- 
petitively inhibit  normal  Lck  function  in  immature  thy- 
938  P,.equirement  for p56  ;~t' Activation in Thymic Selection Table 1.  Effect of DLGKR Tg on Endogenous Superantigen-induced Thymocyte Deletion 
Percent 
Mouse  CD4 SP 
Expt.  1  strain  thymocytes  V[38.2 
Percent TCRV6 positive cells in CD4 SP thymocytes 
V[36  V[311  V137  V[35 
B6  13.70  •  1.11  11.82 •  0.09  8.22  •  0.15  1.72 -+ 0.15  2.89  +  0.11  1.84 -  0.31 
(CBA/J ￿  B6)F1Tg-  13.56 -+ 0.75  18.79 ___ 0.09  0.59 +  0.07  0.61  •  0.18  2.66  •  0.29  0.21  +  0.05 
(CBA/J ￿  B6)FITg  +  9.70 --- 0.45  18.73 •  0.27  0.58  +  0.05  0.67  •  0.12  3.29  •  0.40  0.21  -+ 0.03 
Percent 
Mouse  CD8 SP 
strain  thymocytes  V[38.2 
Percent TCRV[3 positive cells in CD8 SP thymocytes 
V66  VI311  V67  V65 
Expt.  2 
B6  4.32  _  0.52  8.44  +  0.54  6.29  •  0.05  4.60  •  1.17  6.45  m 0.30  12.89  +  1.32 
(CBA/J X B6)F~Tg-  3.46  •  0.32  14.12 +  0.28  0.15  •  0.05  3.25  •  0.46  1.78 +  0.29  1.49 +  0.59 
(CBA/J ￿  B6)F1Tg +  3.07  +  0.21  14.64  •  0.35  0.74 •  0.06  2.44  +  0.08  2.64  •  0.28  1.22 •  0.25 
Percent 
Mouse  CD4 SP 
strain  thymocytes 
Percent TCRV[3 positive cells in CD4 SP thymocytes 
V[38.2  VI36 
B6  11.85 +  1.39  15.16 -  3.32  7.67  +  0.10 
(CBA/J ￿  B6)F~Tg-  11.26  +  1.64  17.34 +  1.54  0.59  +  0.27 
(CBA/J ￿  B6)F1Tg +  7.74  +  0.87  17.44 •  0.85  0.75  -  0.24 
Percent 
Mouse  CD8 SP 
strain  thymocytes 
Percent TCRV[3 positive cells in CD4 SP thymocytes 
V[38.2  V[36 
B6  3.45  +  0.66  8.78  •  0.51  5.77  +  0.39 
(CBA/J X B6)F1Tg-  4.37  -  1.06  12.45 ___  1.33  0.21  +  0.09 
(CBA/J x  B6)F1Tg +  3.37  •  0.43  12.14 +_  1.88  0.47  •  0.12 
Thymocytes from normal B6 and heterozygous DLGKR mice with (CBA/J X B6)F  1  background were stained with anti-CD4-PE, anti-CD8-APC, 
and mAbs  specific for TCRV~6 (44-22-1), TCRV[311 (RR3-15), TCRVI35 (MR9-4), and TCRV~8.2 (F23.2). Goat anti-rat Ig-FITC was used 
for anti-TCRV[36, anti-TCRVI311, and anti-TCRV~5 stainings.  Goat anti-mouse Ig-FITC was used for anti-TCRV[38.2 staining. TCRVI37 stain- 
ing was done with FITC-labeled TR310 mAb. Percentages were calculated from 400,000 viable cells. Percentages of V~6-, V1311-, V~7-, V[35-, 
and V138.2-bearing  cells in CD4 and CD8 SP thymocytes are demonstrated with standard deviations. In expt. 1, three B6 mice, four (CBA/J  X 
B6)F1 Tg- LM mice, and five (CBA/J X B6)F  I Tg  + mice  were analyzed at 6 wk of age. In Expt. 2, three B6 mice, five (CBA/J X B6)F  l Tg-LM 
mice, and four (CBA/J X B6)Fl Tg  + mice were analyzed at 8 wk of age. Statistically  significant  differences (P <0.001 in Expt. 1 and P <0.05 in 
Expt. 2) appear in boldface type. 
mocyte  (32).  Here  we  use  these  animals to  demonstrate 
that the catalytic activity of Lck contributes to TCR-driven 
selection of mature T-lineage cells. 
Our studies made use of a single line of DLGKR animals 
in  which  expression  of LckR273  protein  in  thymocytes 
was  approximately equivalent to  that  of the  endogenous, 
wild-type protein  (Fig.  4  A).  This level of transgene ex- 
pression resulted in an ~50%  compromise in coreceptor- 
associated  phosphotransferase  activity,  demonstrating that 
the LckR273  protein does  indeed compete with its wild- 
type  counterpart  (Fig.  4  B).  Although  transgene-derived 
protein was expressed at only modest levels, positive selec- 
tion, defined either as the representation of CD69 +, CD3  hi 
cells, or using the  H-Y TCR-et/[3 and DO10 TCR-o~/[5 
transgene, was inhibited by 30% in heterozygotes,  and by 
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60% in mice bearing two copies of DLGKR (Figs.  2, 3, 6, 
and 7).  These  results,  representing two  points of a  dose- 
response curve,  do  not by themselves provide any insight 
into the  nature of the  signaling process  that  the  DLGIZR 
transgene interdicts. However, as in the case  of the proxi- 
mal promoter-driven LGKR transgene, where  equimolar 
expression of wild-type (endogenous) and catalytically in- 
active protein produced a 50% reduction in thymus cellu- 
larity (32),  our ability to  detect  a  DLGKR effect permits 
the  inference that  functional Lck  protein must  ordinarily 
exist in a stable, titratable complex. 
Does ILk Deliver Signals from the TCR Itself?.  As much as 
50% of Lck protein associates constitutively with the CD4 
and CD8 coreceptors in DP cells (60). Moreover, corecep- 
tor  expression is  required  for  the  differentiation of most functional  T  cells  (69,  70).  Hence it is possible that the ti- 
tratable complex for which the LckP,273 protein competes 
involves binding to CD4 and CDS.  However, several con- 
siderations  confound  this  interpretation.  First,  reconstitu- 
tion  of CD4 -/-  mice  with  CD4  transgenes  encoding  a 
truncated  form of CD4  that lacks interaction  sites for Lck 
permitted  recovery  of CD4  SP  cells  (71).  Similarly,  the 
Lck-CD8cl  interaction  appears  dispensable  for differentia- 
tion of class I-restricted T  cells when examined in an anal- 
ogous  system  (37).  Xu  and  Littman  (36)  have  also  shown 
that  although  Lck  is  required  for  CD4-dependent  TCR. 
signaling in  a  hybridoma  cell line,  this  effect does  not  de- 
pend upon the kinase activity of Lck, but rather on its pro- 
tein  interaction  (notably  SH3)  domains  (36).  Hence,  the 
inhibition  of positive selection that we observe in DLGKR 
mice  may not  depend  upon  its  interaction  with  corecep- 
tors.  Indeed,  the  TCR.-derived  signals  that  require  Lck in 
the Jurkat cell line do not involve either CD4 or CD8 (35). 
Similarly, the interdiction  of pre-TCR  signals by LckR273 
protein,  and the ability of activated Lck to mimic these sig- 
nals,  are both  coreceptor independent  (32,  72).  From  this 
perspective,  it seems likely that the DLGKR-derived  pro- 
tein competes with its endogenous  counterpart  for interac- 
tion  with  the  TCt<  complex  itself,  and  thereby  blocks 
downstream activation events. 
Distinguishing Positive and Negative Selection.  Biochemical 
studies  suggest  that  Lck acts very early during  the  normal 
TC1L signaling cascade,  in part by phosphorylating imnm- 
noreceptor  tyrosine-based  activation  motif  (ITAM)  res- 
idues  in  the  CD3y,  8,  ~,  and  TCP,-~  proteins,  and  by 
phosphorylating (and thereby activating) the zeta-associated 
protein  (ZAP)  70 kinase  (73), with which  it interacts  (74). 
Indeed,  TC1L-~  phosphorylation  is  reduced  in  DLGKR 
mice  (Fig.  5).  Hence the presence  of the LckR.273  inhibi- 
tory protein  should  serve to attenuate  ZAP-70  activation. 
Prior studies in humans  and mice show  that ZAP-70  con- 
trols  the  maturation  of SP  cells  from DP  progenitors  (75, 
76), so it is perhaps unsurprising that DLGKR  exerts its ef- 
fects at the same point.  However,  both positive and nega- 
tive  selection  are  substantially  interdicted  in  mice  lacking 
ZAP-70  (75).  Can Lck be required  only for TCR.-derived 
signals that mediate positive selection? We suspect not, par- 
ticularly since some superantigen-mediated  deletion  events 
are  partially  reversed  by  DLGKR  transgene  (Table  1). 
However,  a more comprehensive  analysis will be required 
to assess  the  quantitative  influences  of Lck on negative se- 
lection. 
Lck Behaves Uniquely.  By  directing  the  expression  of 
catalytically inactive  Lck protein  to  cells  that have  already 
reached  the  DP  stage,  we  have  learned  that  the  kinase 
function  of Lck  contributes  to  TCR.-derived  signals  that 
regulate  positive  selection.  Although  both  Lck and  p59.6'n 
(Fyn)  have been  shown  to participate  in  the  TCR.-associ- 
ated signaling cascade, Lck plays a pivotal role in these de- 
velopmental  events.  Signaling  from  the  TCP.  is  indeed 
compromised  in fyn -/-  mice  (77),  however  this  impedi- 
ment  arises  only  in  SP  cells,  perhaps  because  Fyn  is  ex- 
pressed  at  only  very  low  levels  in  the  DP  compartment 
(78).  More  to  the point,  high  level  expression  of catalyti- 
cally  inactive  Fyn  does  not  inhibit  thymocyte  develop- 
ment,  which  also  proceeds  normally  in fyn -/-  mice  (as 
above). In this context, although Fyn protein was expressed 
at  normal  levels  and  retained  normal  activity  in  DLGKP, 
mice  (data  not  shown),  it  clearly  could  not  substitute  for 
Lck.  These  observations  are  again  reminiscent  of  those 
made  in  studying  pre-TCR  signaling,  where  Lck  expres- 
sion is uniquely required for normal development. 
Our analysis of the DLGKR  mice suggests  that  Lck ac- 
tivity  will  prove  essential  for  all  TCR-derived  signaling 
events,  In  addition,  the  profound  effects  resulting  from 
modest  expression  of this  transgene  encourage  the  view 
that variations  in  Lck expression  in the  human  population 
may  influence  repertoire  selection,  and  hence  may  affect 
susceptibility to autoimmune and infectious diseases. 
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